BioAtla (BCAB) EPS (Diluted) (2020 - 2026)

BioAtla (BCAB) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 BioAtla 5.74 Mn 5.74 Mn - -6.19

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.19
Dec 31, 2025 -7.80
Sep 30, 2025 -13.00
Jun 30, 2025 -22.45
Mar 31, 2025 -15.02
Dec 31, 2024 -16.16
Sep 30, 2024 -12.26
Jun 30, 2024 -23.61
Mar 31, 2024 -491.68
Dec 31, 2023 -28.44
Sep 30, 2023 -35.68
Jun 30, 2023 -140.43
Mar 31, 2023 -29.27
Dec 31, 2022 -35.85
Sep 30, 2022 -3,677.69
Jun 30, 2022 -121.69
Mar 31, 2022 -33.01
Dec 31, 2021 -34.38
Sep 30, 2021 -33.81
Jun 30, 2021 -45.10